Last reviewed · How we verify
NCT06040710: AQUASNARE
Artificial-intelligence-based QUAntification of Size measuremeNts of Adenoma in Routine Endoscopy
trial testing POSEIDON size estimation software with the EndoMind polyp detection system in Colorectal Polyp in 145 participants. Completed in 28 March 2024.
28 March 2024
Quick facts
| Lead sponsor | Wuerzburg University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 145 |
| Start date | 14 February 2024 |
| Primary completion | 28 March 2024 |
| Estimated completion | 28 March 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- POSEIDON size estimation software with the EndoMind polyp detection system
Conditions studied
- Colorectal Polyp — all drugs for Colorectal Polyp →
- Colorectal Adenoma — all drugs for Colorectal Adenoma →
Sponsor
Wuerzburg University Hospital
Who can join
18 and older, any sex, with Colorectal Polyp or Colorectal Adenoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Polyp size and count determines the follow-up intervals after colonoscopy. However, relying on the endoscopist's optical diagnosis for size estimation has shown considerable variability, leading to erroneous surveillance intervals and increased colorectal cancer risk. This study aims to assess the effectiveness of a new polyp size estimation software, called POSEIDON, which uses the tip of the auxiliary water-jet as reference and is implemented together with the EndoMind polyp detection system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06040710
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Polyp
Currently open trials in the same condition.
- NCT06791408 — Clinical Study on the Accuracy of Real-time AI-assisted Endocytoscopy in the Diagnosis of Colorectal Diminutive Polyps · recruiting
- NCT06715384 — Evaluation of a CAM System for Colorectal Polyp Size Measurement · NA · recruiting
- NCT06193356 — Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable · NA · recruiting
- NCT06502704 — Bile Acids and Microbiome in Early Colorectal Carcinogenesis · recruiting
- NCT06447012 — Artificial Intelligence Development for Colorectal Polyp Diagnosis · recruiting
Other Wuerzburg University Hospital trials
Trials by the same sponsor.
- NCT07084480 — Giant Cell Arteritis - Ways to Precision Medicine · recruiting
- NCT07040189 — Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders · NA · not yet recruiting
- NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
- NCT07108569 — Ability of Physicians to Distinguish Real From Artificial Colon Polyp Images · NA · completed
- NCT06553326 — EndoStyle: Artificial Intelligence Image Transformation Tool for Colonoscopy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06040710 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wuerzburg University Hospital
- Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06040710.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing